Please login to the form below

Not currently logged in
Email:
Password:

Letairis

This page shows the latest Letairis news and features for those working in and with pharma, biotech and healthcare.

Gilead receives FDA approval for PAH combo

Gilead receives FDA approval for PAH combo

Gilead receives FDA approval for PAH combo. Letairis with tadalafil given the nod for pulmonary arterial hypertension. ... Gilead has received FDA approval for the use of Letairis in combination with tadalafil for the treatment of pulmonary arterial

Latest news

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics